Conjugated

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Women's Health & Hormones treatment.

🧴 Clinical Application

Take orally 0.625 mg once daily with water, with or without food. Administer at the lowest effective dose for the shortest duration consistent with treatment goals. In women with an intact uterus, an appropriate progestogen MUST be co-prescribed for 12-14 days each month to protect against endometrial hyperplasia and carcinoma.

⚠️ Side Effects

Common: Breast tenderness, nausea, headache, fluid retention/edema, leg cramps, breakthrough bleeding, and abdominal bloating. Rare/Severe: Endometrial cancer (if unopposed by progestin), breast cancer, venous thromboembolism (DVT/PE), stroke, myocardial infarction, and gallbladder disease.

🛡️ Safety Warnings

Black Box Warning: Unopposed estrogens in women with a uterus increase the risk of endometrial cancer; increased risk of stroke, DVT, pulmonary embolism, and breast cancer (WHI study). Contraindicated in undiagnosed abnormal genital bleeding, known or suspected breast or estrogen-dependent cancer, active DVT/PE, arterial thromboembolic disease, and severe liver dysfunction.